Freddie Mac Appoints Matthew Abrusci General Counsel
Brings 30+ years of legal experience across the financial services sector
Get Alerts FMCC Hot Sheet
Join SI Premium – FREE
MCLEAN, Va., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today announced that Matthew D. Abrusci has joined the company as EVP, General Counsel and Corporate Secretary, effective today. Abrusci brings more than three decades of financial services experience spanning banking, capital markets and securities law.
“Matthew Abrusci brings deep experience across the legal spectrum, and I have no doubt he will quickly become a valued member of Freddie Mac’s executive team,” said Mike Hutchins, president and interim CEO of Freddie Mac.
Abrusci’s background spans top legal positions across the financial services sector, underscoring his value as Freddie Mac takes steps to become more efficient, effective and financially sound. He joins the company from Mitsubishi UFJ Financial Group (MUFG) Americas, where he served as General Counsel. MUFG offers services including commercial banking, trust banking, securities, consumer finance, asset management, leasing, and others. Previously, he held senior legal positions at the Royal Bank of Canada, Credit Suisse Securities (USA) LLC, and Merrill Lynch, & Co., Inc.
Abrusci received a bachelor’s degree and his juris doctorate from St. John’s University.
About Freddie Mac
Freddie Mac’s mission is to make home possible for families across the nation. We promote liquidity, stability and affordability in the housing market throughout all economic cycles. Since 1970, we have helped tens of millions of families buy, rent or keep their home. Learn More: Website | Consumers | X | LinkedIn | Facebook | Instagram | YouTube
MEDIA CONTACT: Christopher Spina
703-388-7031
[email protected]
Source: Freddie Mac
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Earth Science Tech, Inc. (ETST) Acquires Zoolzy LLC to Drive Margin Expansion and Strategic Entry into the Veterinary Market
- Hematogenix's MM MRD Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb's ZENBEXUS™, the First Approved CELMoD Therapy for Multiple Myeloma
- TruHeight and Creator Quincy Helsel Return to Denver for the 2nd Annual Quincy's Community Classic
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Credit Suisse, BofA/Merrill LynchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share